Free Trial

Canopy Growth (TSE:WEED) Cut to Underperform at ATB Capital

Canopy Growth logo with Medical background

ATB Capital downgraded shares of Canopy Growth (TSE:WEED - Free Report) from a sector perform rating to an underperform rating in a report released on Tuesday,BayStreet.CA reports. ATB Capital currently has C$4.00 price target on the stock, down from their prior price target of C$6.00.

Canopy Growth Stock Performance

WEED traded up C$0.06 during trading on Tuesday, hitting C$4.38. The company's stock had a trading volume of 1,276,253 shares, compared to its average volume of 2,073,750. Canopy Growth has a one year low of C$3.74 and a one year high of C$20.50. The business's 50 day simple moving average is C$5.74 and its 200-day simple moving average is C$7.64. The company has a quick ratio of 2.32, a current ratio of 2.15 and a debt-to-equity ratio of 117.00. The firm has a market cap of C$371.69 million, a PE ratio of -0.55, a P/E/G ratio of -0.01 and a beta of 1.79.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Read More

Should you invest $1,000 in Canopy Growth right now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Strong Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines